Description
Dianabol Oil is the oily injection form of Methandrostenolone (Dianabol). The same compound as classic oral Dianabol, just in oily vehicle for intramuscular administration instead of as tablet. Injection bypasses first-pass hepatic metabolism, reducing hepatic load.
Per study reports pharmacology remains identical to oral Dianabol: binding to the androgen receptor, moderate aromatization to estradiol, rapid action onset times, marked water retention and pump effects. Anabolic action per milligram remains the same but bioavailability is higher with injection (95%+ vs 70-90% oral).
The main advantage of the injectable form: substantially reduced hepatotoxicity. Classical oral Dianabol travels through the liver with every swallow; the injection distributes systemically without this first-pass effect. ALT/AST rises under Dianabol injection are measurably lower in available data than under the oral form.
Pharmacokinetically the oily injection has a longer effective half-life than the tablet (~6-8 hours vs ~3-6 hours) because release from the oil depot is delayed. This means 1-2 injections per day often suffice.
Known effects are the same as under oral Dianabol: rapid mass gain, water retention, estrogen-mediated effects (gynecomastia research findings possible), hypertension, HPG suppression. Lipid profile worsening less pronounced than with oral form.
Methandrostenolone is on the WADA banned list.
You can order Dianabol Oil as an oily injection solution in 10-pack at 50mg/ml.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
Dianabol Oil bypasses first-pass hepatic metabolism and is therefore gentler on the liver in the available data than the oral tablet - but the substance remains 17-alpha-methylated and intervenes broadly in the hormonal system.
Documented in studies and the application literature:
- Hepatotoxicity: Methandrostenolone is 17-alpha-methylated and thus hepatotoxic even in injection form. ALT/AST elevations are documented that, per class comparison, are measurably lower than under the oral form but are not negligible.
- Estrogen conversion: Methandrostenolone aromatizes moderately to estradiol. Pronounced water retention, pump effects and gynecomastia research findings at higher doses are documented.
- Suppression of endogenous production: Dianabol suppresses the HPG axis. Reduced endogenous testosterone production and testicular atrophy are documented, a test base is customary in research practice.
- Cardiovascular: the literature describes hypertension and unfavorable shifts in the lipid profile, the latter less pronounced than with the oral form.
Baseline bloodwork before, during and after a research protocol is strongly advised. This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- The anabolic steroid methandienone targets the hypothalamic-pituitary-testicular axis and myostatin signaling in a rat training model - Archives of Toxicology 2011, Frankenberg et al: shows HPG axis suppression and myostatin effects under methandienone.
- Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol) - Clinical Science 1986, Cuneo et al: insulin action and glucose dynamics under Dianabol.
- Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone) - Cancer 1977, Sweeney et al: classical case report on liver adenoma under long-term methandienone.
- Effect of an anabolic steroid (methandienone) on pituitary-adrenal function in the human - Journal of Endocrinology 1962, Sereda et al: early investigation of the hypothalamic-pituitary axis.
- Identification of metabolites of the anabolic steroid methandienone formed by bovine hepatocytes in vitro - The Analyst 1998, Schänzer et al: hepatic metabolism of methandienone.
